MedTrace Logo

Routine Hysteroscopy in IVF/ICSI Cycles in Patients With Primary Unexplained Infertility

NCT02416596 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 680

Last updated 2015-04-15

No results posted yet for this study

Summary

The aim of the present study is to evaluate the impact of hysteroscopy prior to starting the IVF (in vitro fertilisation) cycle on treatment outcome in women with unexplained primary infertility.

Conditions

  • Primary Infertility Unspecified
  • Infertility
  • Ovarian Hyperstimulation
  • Pregnancy

Interventions

PROCEDURE

Hysteroscopy

Office hysteroscopy will be performed during the Luteal phase of the proceeding menstrual cycle. All OH (office hysteroscopy) procedures will be performed with a vaginoscopic approach without utilizing a speculum and applying traction to the cervix with a tenaculum. Antibiotic prophylaxis: None OH will be cancelled until after treatment of vaginal infection.

DEVICE

Hysteroscope

The device used is a rigid hysteroscope (continuous flow, 30 degree forward oblique view) assembled in a 4-mm diameter diagnostic sheath with an atraumatic tip (Karl Storz Endoscopy). Illumination: High intensity cold light source and fiberoptic cable Distention medium: solution of 0.9% normal saline with pressure at 100-120 mmHg

Sponsors & Collaborators

  • Ain Shams Maternity Hospital

    lead OTHER

Principal Investigators

  • Khaled H Swaydan, PhD · Ain Shams University (Obs&Gyn)

  • Ahmed K Mekled, PhD · Ain Shams University (Obs&Gyn)

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-12-31
Completion
2017-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02416596 on ClinicalTrials.gov